The decision was made after the Ministry of Health and Population approved Molnupiravir for emergency cases, as the drug has reportedly been able to cut hospitalisation and deaths by 30%.
Rapid antigen tests and Molnupiravir, an oral pill to medicate against COVID-19 by American pharmaceutical company Merck, will be released in public hospital pharmacies. The decision was made after the Ministry of Health and Population approved Molnupiravir for emergency cases amongst high-risk patients, as the drug has reportedly been able to cut hospitalisation and deaths by 30%.
The Ministry of Health and Population has also extended the period in which citizens can take the booster dose against COVID-19. Citizens now have an additional two months after they receive their confirmation message from the Ministry of Health and Population in order to take their booster shot.